HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hematopoietic stem cell transplantation for infantile osteopetrosis.

Abstract
We report the international experience in outcomes after related and unrelated hematopoietic transplantation for infantile osteopetrosis in 193 patients. Thirty-four percent of transplants used grafts from HLA-matched siblings, 13% from HLA-mismatched relatives, 12% from HLA-matched, and 41% from HLA-mismatched unrelated donors. The median age at transplantation was 12 months. Busulfan and cyclophosphamide was the most common conditioning regimen. Long-term survival was higher after HLA-matched sibling compared to alternative donor transplantation. There were no differences in survival after HLA-mismatched related, HLA-matched unrelated, or mismatched unrelated donor transplantation. The 5- and 10-year probabilities of survival were 62% and 62% after HLA-matched sibling and 42% and 39% after alternative donor transplantation (P = .01 and P = .002, respectively). Graft failure was the most common cause of death, accounting for 50% of deaths after HLA-matched sibling and 43% of deaths after alternative donor transplantation. The day-28 incidence of neutrophil recovery was 66% after HLA-matched sibling and 61% after alternative donor transplantation (P = .49). The median age of surviving patients is 7 years. Of evaluable surviving patients, 70% are visually impaired; 10% have impaired hearing and gross motor delay. Nevertheless, 65% reported performance scores of 90 or 100, and in 17%, a score of 80 at last contact. Most survivors >5 years are attending mainstream or specialized schools. Rates of veno-occlusive disease and interstitial pneumonitis were high at 20%. Though allogeneic transplantation results in long-term survival with acceptable social function, strategies to lower graft failure and hepatic and pulmonary toxicity are urgently needed.
AuthorsPaul J Orchard, Anders L Fasth, Jennifer Le Rademacher, Wensheng He, Jaap Jan Boelens, Edwin M Horwitz, Amal Al-Seraihy, Mouhab Ayas, Carmem M Bonfim, Farid Boulad, Troy Lund, David K Buchbinder, Neena Kapoor, Tracey A O'Brien, Miguel A Diaz Perez, Paul A Veys, Mary Eapen
JournalBlood (Blood) Vol. 126 Issue 2 Pg. 270-6 (Jul 09 2015) ISSN: 1528-0020 [Electronic] United States
PMID26012570 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S.)
Copyright© 2015 by The American Society of Hematology.
Topics
  • Child
  • Child, Preschool
  • Female
  • Hematopoietic Stem Cell Transplantation (methods, statistics & numerical data)
  • Histocompatibility Testing
  • Humans
  • Infant
  • Longitudinal Studies
  • Male
  • Osteopetrosis (congenital, mortality, therapy)
  • Siblings
  • Survival Analysis
  • Tissue Donors
  • Unrelated Donors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: